Abstract

REVIEW ON DIFFERENT APPROACHES OF NANOTECHNOLOGY FOR CARDIOVASCULAR DISEASES

Deep M. Solanki*, Rajashri R. Dhonnar, Rutuja S. Shinde, Shweta S. Shelar, Vaibhavi A. Shirke

.

Abstract

Cardiovascular diseases claim many lives globally, and a significant portion of these cases could be prevented. The increase in these diseases is closely tied to diets high in saturated fats, salt, and sugar, along with sedentary lifestyles and rising obesity rates. Currently, the available treatments for cardiovascular diseases are limited to oral medications or invasive surgical procedures. Nanotechnology holds the potential to offer more effective treatments with fewer side effects. In this review, we will explore the future prospects of nanotechnology in the field of cardiovascular medicine. A substantial portion of nanomedicine research in the cardiovascular domain has been dedicated to developing specialized nanoparticles that can enhance targeting, thus addressing biological barriers. In the context of heartrelated conditions like atherosclerosis, hypertension, and myocardial infarction, various types of nanoparticles have been employed. These include liposomes, polymeric nanoparticles, polymeric micelles, and dendrimers, among others. The advancement of nanotechnology, especially in the realm of nanoparticles for drug delivery, has significantly improved our ability to target drugs more effectively, thereby enhancing therapeutic outcomes. Thorough in vivo studies of nanoparticles are invaluable as they offer insights that can shape future treatments.

Keywords: Nanotechnology, Cardiovascular disease, CNT, Nanoparticles, Liposomes.